Skip to main content
OpenTrials
Completed

NCT Number: NCT02978872

Quantra Determination of Coagulation Parameters in Arterial and Venous Blood

The Quantra™ System is a novel point-of-care diagnostic device designed to perform whole blood coagulation analysis. This study compares Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Virginia

Charlottesville, Virginia, 22903, United States

About this study

The Quantra System is a fully integrated and automated in vitro diagnostic device which utilizes SEER Sonorheometry, an ultrasound-based technology, to characterize the dynamic changes in the viscoelastic properties of a blood sample during coagulation and clot lysis. Viscoelastic testing performed using existing technologies is typically performed on arterial samples obtained from patients undergoing surgical procedures, although reference ranges for these tests have been established for venous blood only.

The aim of this study is to evaluate potential differences between Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is scheduled for cardiac surgery, utilizing cardiopulmonary bypass, or including placement of a ventricular assist device
  • Subject is ≥18 years
  • Subject is willing to participate and he/she has signed a consent form
  • Subject may participate if they have a history of bleeding or are on preoperative anticoagulant therapy

Exclusion criteria

  • Subject is unable to provide written informed consent
  • Subject is younger than 18 years
  • Subject is incarcerated at the time of the study
  • Subject is currently enrolled in a study that may confound the results of the proposed study
  • Subject is affected by a condition that, in the opinion of the surgical team, may pose additional risks

Treatment and study plan

Primary outcomes

  1. Comparison of Clot Time and Clot Stiffness results between arterial and venous samples

    Time frame: Up to 24 hours

    Coagulation function assessed by Quantra at 2 time points (Baseline and either during cardiac bypass or post-bypass)

Secondary outcomes

  1. Comparison of Quantra results to standard coagulation test results in venous samples

    Time frame: Up to 24 hours

    Coagulation function assessed by Quantra and standard coagulation tests at 2 time points (Baseline and either during cardiac bypass or post-bypass)

  2. Comparison of Quantra results to comparable ROTEM results in venous samples

    Time frame: Up to 24 hours

    Coagulation function assessed by Quantra and ROTEM at 2 time points (Baseline and either during cardiac bypass or post-bypass)

Sponsors and collaborators

Lead sponsor

HemoSonics LLC

Industry

Collaborators

  • University of Virginia

Registry information

Official study title

Comparison of Coagulation Parameters in Arterial and Venous Blood Measured Using the Quantra System

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Dec 1, 2016
Registry last updated
Apr 19, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.